Latest Batten disease Stories
StemCells, Inc. (Nasdaq:STEM) announced today that it has been awarded a $305,000 grant from the National Institute of Diabetes and Digestive and Kidney Diseases to research and develop a potential cell-based therapeutic for liver disease arising from infection by the hepatitis C virus (HCV).
StemCells, Inc. (NASDAQ:STEM) today announced that Stewart Craig, Ph.D., an acknowledged expert in the development of cell-based therapeutics, will be joining the Company as Senior Vice President, Development and Operations, effective September 15, 2008. Dr.
StemCells, Inc. (NASDAQ:STEM) today announced that it has accepted an invitation by the California Institute of Regenerative Medicine (CIRM) to present on Batten Disease at the upcoming meeting of CIRM's Independent Citizens Oversight Committee (ICOC).
- A volcanic mudflow.